Ariana Katz

Biographic Data

ID	7561680
NAME	Ariana Katz
GIVEN NAMES	Ariana
FAMILY NAME	Katz
SIGNATURE	KATZ A
AFFILIATIONS	RTI International
ORCID	0000-0001-5742-4953
VERIFIED	Yes
TOTAL WORKS	16
TOTAL CITATIONS	0
WORKS AS AUTHOR	16
WORKS AS EDITOR	0
FIRST PUBLICATION YEAR	2017
LATEST PUBLICATION YEAR	2026
H-INDEX	0

Wellness-based HIV prevention counseling for young sexual/gender minorities of color in the United States
Marie C D Stoner, Adam C Sukhija-Cohen et al.ARTICLEAIDS Care2026
Providers often counsel young sexual/gender minority (YSGM) of color about HIV "risk" in ways that feel unrelatable and stigmatizing. Our study explored: (1) needs for sexual wellness-based HIV prevention among 18-29-year-old YSGM of color, (2) challenges and opportunities in using this counseling approach, and (3) preliminary feasibility and acceptability of a wellness-based counseling intervention. Aim 1 collected surveys and in-depth interview…
Creating “Safer Ground”
Open AccessRania Ali, Rebecca Perry et al.ARTICLEBMC Public Health2025
Our findings highlight that when key elements such as cross-sector collaboration, engaged leadership, and flexible funding align, significant progress can be made in providing housing and integrated medical, behavioral, and social services for PEH with complex needs
Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men
Open AccessJennifer Velloza, Albert Y Liu et al.ARTICLEAIDS Care2024
Pre-exposure prophylaxis (PrEP) adherence remains a challenge among young men who have sex with men (MSM). We developed and tested a smartphone application (“app”), “DOT Diary”, which combines automated directly observed therapy (DOT) with information about PrEP protection levels, pill-taking reminders, a sexual behavior diary, and a PrEP dosing calendar. To contextualize trial results, we qualitatively explored participants’ app experiences. The…
Women’s motivations for participating in the dapivirine vaginal ring open label extension study
Kalendri Naidoo, Elizabeth Montgomery et al.ARTICLEAIDS Care2024
Open-Label Extension (OLE) studies are important in the drug development process and are used to further support the licensing applications and regulatory approvals of products. We aimed to understand why women chose to join the HOPE OLE study – where women were offered the dapivirine vaginal ring after two pivotal trials were completed – through data collected from individual in-depth interviews. Ten women at each of the six HOPE research sites …
Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study
Open AccessKalendri Naidoo, Montgomery Elizabeth T et al.ARTICLEAIDS and Behavior2022
Women’s experience receiving drug feedback and adherence counseling in MTN-025/Hope - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring
Open AccessAriana Katz, Iván C Balán et al.ARTICLEAIDS and Behavior2022
Ring-ing in the Future
Open AccessKrishnaveni Reddy, Florence Mathebula et al.ARTICLEAIDS and Behavior2022
Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention
Open AccessAriana Katz, Leila E Mansoor et al.ARTICLEAIDS and Behavior2021
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial
Open AccessJuliane Etima, Ariana Katz et al.ARTICLEAIDS and Behavior2021
Impact of Women’s Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa
Open AccessMargaret W Gichane, Ariana Katz et al.ARTICLEAIDS and Behavior2021
Men’s Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe
Open AccessElizabeth Montgomery, Ariana Katz et al.ARTICLEAIDS and Behavior2021
Counselors’ acceptability of adherence counseling session recording, fidelity monitoring, and feedback in a multi-site HIV prevention study in four African countries
Open AccessRebecca Giguere, Cody Lentz et al.ARTICLEAIDS Care2020
Biomedical HIV prevention trials increasingly include evidence-based adherence counseling to encourage product use. To retain effectiveness, interventions must contain key components. Monitoring counseling fidelity ensures inclusion of components but is challenging in multinational contexts with different languages and scarce local supervision. The MTN-025/HOPE Study, a Phase 3b open-label trial to assess continued safety of and adherence to the …
The Power of the Shared Experience
Open AccessAriana Katz, Kalendri Naidoo et al.ARTICLEAIDS and Behavior2020
Hygiene, Blood Flow, and Vaginal Overload
Open Accessthe MTN-020/ASPIRE Study Team, Zoe Duby et al.ARTICLEAIDS and Behavior2019
Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa
Miria Chitukuta, Zoe Duby et al.ARTICLECulture Health & Sexuality2019
Rumours may influence health-related behaviours, including the uptake of and adherence to HIV prevention products. This study assessed the safety and effectiveness of a vaginal ring delivering the antiretroviral dapivirine for HIV prevention in Africa. We explored negative rumours about study participation and the vaginal ring amongst study participants and their communities in Malawi, Uganda, South Africa and Zimbabwe. In total 214 women partici…
How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe
Open AccessPetina Musara, Elizabeth Montgomery et al.ARTICLEAIDS and Behavior2017